Dimension Therapeutics, Inc. 4
4 · Dimension Therapeutics, Inc. · Filed Feb 2, 2016
Insider Transaction Report
Form 4
Wadsworth Samuel C.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-02-01+50,000→ 50,000 totalExercise: $7.14Exp: 2026-01-31→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This stock option vests in forty-eight (48) equal monthly installments beginning on January 27, 2016.